The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.c

Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)

Publications

Souza CA, Müller NL, Johkoh T, Akira M

Drug-induced eosinophilic pneumonia: high-resolution CT findings in 14 patients.

AJR. American journal of roentgenology 2006 Feb;186;368-73 — 2006 Feb — 368-73

Burgher LW, Kass I, Schenken JR

Pulmonary allergic granulomatosis: a possible drug reaction in a patient receiving cromolyn sodium.

Chest 1974 Jul;66;84-6 — 1974 Jul — 84-6

Löbel H, Machtey I, Eldror MY

Pulmonary infiltrates with eosinophilia in an asthmatic patient treated with disodium cromoglycate.

Lancet (London, England) 1972 Nov 11;2;1032 — 1972 Nov 11 — 1032

Repo UK, Nieminen P

Pulmonary infiltrates with eosinophilia and urinary symptoms during disodium cromoglycate treatment. A case report.

Scandinavian journal of respiratory diseases 1976;57;1-4 — 1976 — 1-4